Event Brief
Apr 6, 2026 at 10:07 PM ET
Celltrion's Truxima Dominates U.S. Prescription Market
By The BriefBrief
Celltrion's Truxima leads the U.S. prescription market as of February 2026.
WHO: Celltrion Inc.
WHAT: Truxima leads U.S. prescription market
WHEN: Apr 6, 2026 at 9:46 PM ET
WHERE: USA
WHY: No specific cause was reported.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
